Bio-Rad Laboratories, Inc. BIO.B Gain (Loss), Foreign Currency Transaction, before Tax
Gain (Loss), Foreign Currency Transaction, before Tax at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ForeignCurrencyTransactionGainLossBeforeTax.
The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories, Inc.'s gain (loss), foreign currency transaction, before tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories, Inc.'s gain (loss), foreign currency transaction, before tax?
- Bio-Rad Laboratories, Inc. (BIO.B) reported gain (loss), foreign currency transaction, before tax of $2.4M in Q1 2026.
- How has Bio-Rad Laboratories, Inc.'s gain (loss), foreign currency transaction, before tax changed year-over-year?
- Bio-Rad Laboratories, Inc.'s gain (loss), foreign currency transaction, before tax decreased by 11.1% year-over-year, from $2.7M to $2.4M.
- What is the long-term trend for Bio-Rad Laboratories, Inc.'s gain (loss), foreign currency transaction, before tax?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories, Inc.'s gain (loss), foreign currency transaction, before tax has grown at a 24.4% compound annual growth rate (CAGR), from -$2.75M to $6.6M.